Epidemiology of pharmaceutically treated depression and treatment resistant depression in South Korea
Open Access
- 23 August 2019
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (8), e0221552
- https://doi.org/10.1371/journal.pone.0221552
Abstract
The epidemiology of pharmaceutically treated depression (PTD) and treatment resistant depression (TRD) is largely unknown in South Korea. The aim of this study was to develop a greater understanding of the characteristics of PTD and TRD in nearly the entire adult population in South Korea using the Health Insurance Review and Assessment Service (HIRA). Diagnostic codes and prescription data for South Korean adults were extracted from the HIRA. Subjects were included in the PTD cohort if they received at least one prescription for antidepressants and were diagnosed with depression. TRD was defined as PTD having two or more regimen failures of antidepressants or antipsychotics. In 2012, there were 41,256,396 adults in South Korea with 834,694 meeting the criteria for PTD (2.0%). Among subjects with PTD, 57% stopped treatment in less than 28 days of antidepressant supply. Tricyclic and tetracyclic antidepressants were the most frequently used antidepressants as a first-line regimen for PTD (44.3% of PTD) followed by selective serotonin reuptake inhibitors (32.1% of PTD). Results also indicated that 34,812 subjects developed TRD (4.2% of PTD). Median PTD and TRD durations were 28 and 623 days respectively. Proportions of psychiatric and non-psychiatric comorbidities were higher in TRD cases than in PTD cases that were not treatment resistant. Despite a small proportion of patients with TRD, the prolonged duration of illness and higher comorbidity implies the need for better treatment.This publication has 32 references indexed in Scilit:
- A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996–2013Psychiatric Services, 2014
- Characterization of Treatment Resistant Depression Episodes in a Cohort of Patients from a US Commercial Claims DatabasePLOS ONE, 2013
- What is the meaning of treatment resistant/refractory major depression (TRD)? A systematic review of current randomized trialsEuropean Neuropsychopharmacology, 2007
- Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D ReportAmerican Journal of Psychiatry, 2006
- Treatment-resistant depression.2006
- Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical PracticeAmerican Journal of Psychiatry, 2006
- A One-Year Comparison of Vagus Nerve Stimulation with Treatment as Usual for Treatment-Resistant DepressionBiological Psychiatry, 2005
- Treatment‐resistant depression: resistant to definition?Acta Psychiatrica Scandinavica, 2005
- Diagnosis and definition of treatment-resistant depressionBiological Psychiatry, 2003
- Global burden of depressive disorders: The issue of durationThe British Journal of Psychiatry, 2002